COVID 19 Vaccine for Adolescents. Concern about Myocarditis and PericarditisOpinion Published on 2021-09-012022-10-29 Journal: Pediatric Reports [Category] COVID-19, [키워드] acute SARS-CoV-2 infection administration concern COVID 19 COVID-19 COVID-19 mRNA vaccine criteria Critically ill discharged home disease European Evidence Health Inflammatory Kawasaki-like syndrome male Moderna mRNA-based vaccine multi-system inflammatory disease myocarditis occurred Patient Pericarditis Pfizer–BioNTech SARS-CoV-2 second dose syndrome the patient the vaccine Vaccine vaccine administration [DOI] 10.3390/pediatric13030061 PMC 바로가기 [Article Type] Opinion
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021성인의 COVID-19 관련 입원에 대한 Pfizer-BioNTech 및 Moderna 백신의 지속적인 효과 — 미국, 2021년 3월–7월Full Report Published on 2021-08-272022-09-10 Journal: Morbidity and Mortality Weekly Report [Category] MERS, 변종, [키워드] Against COVID-19 Moderna Pfizer-BioNTech United States [DOI] 10.15585/mmwr.mm7034e2 PMC 바로가기 [Article Type] Full Report
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021SARS-CoV-2 B.1.617.2(델타) 변종 — National Healthcare Safety Network, 3월 1일– 2021년 8월 1일Full Report Published on 2021-08-272022-09-10 Journal: Morbidity and Mortality Weekly Report [Category] MERS, SARS, 변종, [키워드] B.1.617.2 Delta home Moderna network Nursing Pfizer-BioNTech Preventing resident Safety SARS-CoV-2 the SARS-CoV-2 [DOI] 10.15585/mmwr.mm7034e3 PMC 바로가기 [Article Type] Full Report
Case Report: Two Cases of Subacute Thyroiditis Following SARS-CoV-2 VaccinationMedicine Published on 2021-08-242022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] clinical coronavirus COVID-19 cytological described develop disorder first dose Inflammatory Laboratory Moderna Neck pain Pain receiving reported SARS-CoV-2 SARS-CoV-2 vaccination Side effect Spain Subacute Subacute thyroiditis Thyroid Thyroiditis vaccination viral infections [DOI] 10.3389/fmed.2021.737142 PMC 바로가기 [Article Type] Medicine
Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design studyBNT162B2 및 mRNA-1273 증상 SARS-COV-2 감염에 대한 COVID-19 백신의 효과 및 캐나다 온타리오 주 온타리오의 심각한 COVID-19 결과 : 테스트 부정적인 설계 연구Research Published on 2021-08-202022-09-10 Journal: The BMJ [Category] MERS, SARS, 변종, 진단, [키워드] 95% confidence interval adjusted BNT162b2 Canada Chain Reaction Clinical characteristics Community comparable death died dose doses E484K E484K mutation effective Effectiveness estimate first dose hospital Hospital admission Hospital admissions interval intervals Logistic regression Moderna mRNA mRNA COVID-19 vaccines mRNA-1273 multivariable logistic regression objective of BNT162b2 Older Older adults outcome outcome measure outcomes participant people with symptoms Pfizer-BioNTech polymerase chain polymerase chain reaction positive Result reverse transcription reverse transcription polymerase chain reaction RT-PCR SARS-CoV-2 SARS-COV-2 infection setting Symptom symptomatic infection symptomatic SARS-CoV-2 infection Test test negative tested Vaccine variant variants younger people [DOI] 10.1136/bmj.n1943 PMC 바로가기 [Article Type] Research
A Case of Acute Pulmonary Embolus after mRNA SARS-CoV-2 ImmunizationCase Report Published on 2021-08-142022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] acute respiratory syndrome adenovirus-based adverse event Anticoagulant AstraZeneca BNT162b2 mRNA vaccine ChAdOx1 nCoV-19 vaccine clinician contribute coronavirus coronavirus disease COVID-19 COVID-19 pandemic Critical effective Embolus janssen knowledge Moderna mRNA mRNA-1273 Multiple overcome pandemic Patient Pfizer-BioNTech positive pulmonary Pulmonary emboli Pulmonary embolus reported Safe SARS-CoV-2 SARS-CoV-2 vaccine second dose vaccination Vaccine Vaccines Venous Thromboembolism VTE while [DOI] 10.3390/vaccines9080903 PMC 바로가기 [Article Type] Case Report
FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health systemFDA 승인 mRNA COVID-19 백신은 여러 주 의료 시스템에서 합성된 실제 증거에 따라 효과적입니다.Article Published on 2021-08-132022-09-11 Journal: Med (New York, N.Y.) [Category] Coronavirus, SARS, 임상, 진단, [키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Admission BNT162b2 Clinical outcome clinical outcomes clinical trials Cohort coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccines demonstrated dose drug Drug administration effective Effectiveness Efficacy Evidence Features food health system Healthcare system Hospitalization ICU ICU admission incidence rate incidence rates individual intensive care Mayo Clinic Moderna mRNA mRNA COVID-19 vaccine mRNA vaccines mRNA-1273 PCR testing Pfizer/BioNTech Phase 3 positive propensity score matching randomized clinical trials real world evidence. reduced Retrospective analysis SARS-CoV-2 SARS-COV-2 infection Vaccine vaccine dose [DOI] 10.1016/j.medj.2021.06.007 PMC 바로가기 [Article Type] Article
Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare WorkersArticle Published on 2021-08-052022-10-28 Journal: Biology [Category] COVID-19, [키워드] adverse effects age approved AstraZeneca BTN162 vaccine carried ChAdOx1 COVID-19 vaccine chill conducted coronavirus COVID-19 COVID-19 pandemic COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines cross-sectional Cross-sectional studies demographic data drug-related side effects and adverse reactions Effect ENhance evaluate females Gender Germany Health personnel healthcare healthcare worker increased risk injection site injection site pain joint knowledge Local majority malaise methodology Moderna mRNA-1273 vaccine mRNA-based mRNA-based vaccine mRNA-based vaccines overcome Pain parameters participant Pfizer-BioNTech Prevalence questionnaire reliability reported resolved risk factor safety point side Side effect simple systemic side effect systemic side effects tested vaccination Vaccine Vaccine hesitancy Vaccines viral vector-based worker [DOI] 10.3390/biology10080752 PMC 바로가기 [Article Type] Article
Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case reportCase Report Published on 2021-08-042022-10-27 Journal: BMC Public Health [Category] COVID-19, [키워드] abnormality adverse event Analysis Aspirin Cardiac MRI Case report chest pain clinician Colchicine COVID-19 COVID-19 infection COVID-19 mRNA Vaccination COVID-19 vaccine Diagnosis discharge dose ECG elevated Emergency use authorization Evidence first dose healthy highlight hospital Hospitalization imperative male mechanism Mild Moderna mRNA-1273 myocardial injury Myopericarditis pandemic Patient Pfizer pleuritic produced safety profile SARS-CoV-2 Side effect supplementary material Symptoms symptoms prior Vaccine Vaccines were assessed [DOI] 10.1186/s12872-021-02183-3 PMC 바로가기 [Article Type] Case Report
Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects건강한 대상에서 mRNA COVID-19 백신에 대한 차등 항체 반응Research Article Published on 2021-08-042022-09-10 Journal: Microbiology Spectrum [Category] MERS, SARS, 진단, 치료법, [키워드] Affect age age and gender anti-SARS-CoV-2 antibody antibodies antibody antibody levels Antibody Response Antigen antigens clinical study clinical utility condition Course COVID-19 COVID-19 vaccination dose feasible first and second dose Gender healthy individuals Humoral immunity immunized in healthy individual independent individual induce initial limit marker Moderna Moderna mRNA vaccine mRNA mRNA vaccines multiple antigen multiple antigens no differences not need pandemic personal health Pfizer Population postvaccination response SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 antigens SARS-COV-2 infection second dose specific antibodies Spike protein the antibody response the healthy the vaccine vaccination Vaccine virus-specific antibodies [DOI] 10.1128/Spectrum.00341-21 PMC 바로가기 [Article Type] Research Article